Related references
Note: Only part of the references are listed.ISRIB Blunts the Integrated Stress Response by Allosterically Antagonising the Inhibitory Effect of Phosphorylated eIF2 on eIF2B
Alisa F. Zyryanova et al.
MOLECULAR CELL (2021)
Overcoming hypoxia-induced resistance of pancreatic and lung tumor cells by disrupting the PERK-NRF2-HIF-axis
Alina Kuper et al.
CELL DEATH & DISEASE (2021)
eIF2B conformation and assembly state regulate the integrated stress response
Michael Schoof et al.
ELIFE (2021)
Structural insights into ISRIB, a memory-enhancing inhibitor of the integrated stress response
Aditya A. Anand et al.
FEBS JOURNAL (2020)
Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
Nour Ghaddar et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2020)
Translational control of breast cancer plasticity
Michael Jewer et al.
NATURE COMMUNICATIONS (2020)
The integrated stress response: From mechanism to disease
Mauro Costa-Mattioli et al.
SCIENCE (2020)
Progress in targeting RAS with small molecule drugs
Frank McCormick
BIOCHEMICAL JOURNAL (2019)
Generally applicable transcriptome-wide analysis of translation using anota2seq
Christian Oertlin et al.
NUCLEIC ACIDS RESEARCH (2019)
An integrated stress response via PKR suppresses HER2+cancers and improves trastuzumab therapy
Cedric Darini et al.
NATURE COMMUNICATIONS (2019)
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Herwig P. Moll et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management
Lucie Heinzerling et al.
ESMO OPEN (2019)
Synthetic Lethal Vulnerabilities in KRAS-Mutant Cancers
Andrew J. Aguirre et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
The Unfolded Protein Response and Cell Fate Control
Claudio Hetz et al.
MOLECULAR CELL (2018)
Development of a stress response therapy targeting aggressive prostate cancer
Hao G. Nguyen et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Role of eIF2α Kinases in Translational Control and Adaptation to Cellular Stress
Ronald C. Wek
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer
Myoung-Hee Kang et al.
NATURE COMMUNICATIONS (2018)
Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer
Muhammad Khairi Ahmad et al.
CANCER BIOLOGY & MEDICINE (2018)
Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells
Arun M. Unni et al.
ELIFE (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
The eIF2-alpha kinase HRI: a potential target beyond the red blood cell
Nicholas Burwick et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
A Unique ISR Program Determines Cellular Responses to Chronic Stress
Bo-Jhih Guan et al.
MOLECULAR CELL (2017)
Mutant KRAS promotes malignant pleural effusion formation
Theodora Agalioti et al.
NATURE COMMUNICATIONS (2017)
Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1
Ionica Masgras et al.
CELL REPORTS (2017)
Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer
Juan R. Cubillos-Ruiz et al.
CELL (2017)
CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway
Zhipeng Tang et al.
MOLECULAR ONCOLOGY (2016)
IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis
Gavin D. Brooks et al.
CANCER RESEARCH (2016)
Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules
Elda Grabocka et al.
CELL (2016)
Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo
Laura Brunelli et al.
SCIENTIFIC REPORTS (2016)
KRAS oncogene in lung cancer: focus on molecularly driven clinical trials
Emmanuelle Kempf et al.
EUROPEAN RESPIRATORY REVIEW (2016)
Roles of the translation initiation factor eIF2α serine 51 phosphorylation in cancer formation and treatment
Antonis E. Koromilas
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals
Xudong Wu et al.
CELL RESEARCH (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
HISAT: a fast spliced aligner with low memory requirements
Daehwan Kim et al.
NATURE METHODS (2015)
Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells
Elisa Caiola et al.
ONCOTARGET (2015)
Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer
C. Vanesa Diaz-Garcia et al.
TUMOR BIOLOGY (2015)
A new function and complexity for protein translation initiation factor eIF2B
Martin D. Jennings et al.
CELL CYCLE (2014)
In Vivo Structure-Activity Relationship Studies Support Allosteric Targeting of a Dual Specificity Phosphatase
Vasiliy N. Korotchenko et al.
CHEMBIOCHEM (2014)
Selective mRNA translation during eIF2 phosphorylation induces expression of IBTKα
Thomas D. Baird et al.
MOLECULAR BIOLOGY OF THE CELL (2014)
Targeting RAS-ERK signalling in cancer: promises and challenges
Ahmed A. Samatar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity
Charity Atkins et al.
CANCER RESEARCH (2013)
The transcriptional landscape and mutational profile of lung adenocarcinoma
Jeong-Sun Seo et al.
GENOME RESEARCH (2012)
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
Jeffrey M. Axten et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model
Yifeng Xia et al.
NATURE CELL BIOLOGY (2012)
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
Kadoaki Ohashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer
M. C. Garassino et al.
ANNALS OF ONCOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases
Akihiko Yoshizawa et al.
MODERN PATHOLOGY (2011)
LIM-class homeobox gene Lim1, a novel oncogene in human renal cell carcinoma
V. Dormoy et al.
ONCOGENE (2011)
Five-Year Lung Cancer Survival - Which Advanced Stage Nonsmall Cell Lung Cancer Patients Attain Long-Term Survival?
Tina Wang et al.
CANCER (2010)
Dual-specificity phosphatases: critical regulators with diverse cellular targets
Kate I. Patterson et al.
BIOCHEMICAL JOURNAL (2009)
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Nahum Sonenberg et al.
CELL (2009)
Translation Attenuation through elF2α Phosphorylation Prevents Oxidative Stress and Maintains the Differentiated State in β Cells
Sung Hoon Back et al.
CELL METABOLISM (2009)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages
Gabriela Molina et al.
NATURE CHEMICAL BIOLOGY (2009)
Carbonic anhydrase II and alveolar fluid reabsorption during hypercapnia
Jiwang Chen et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Stat1 Phosphorylation Determines Ras Oncogenicity by Regulating p27Kip1
Shuo Wang et al.
PLOS ONE (2008)
The elF2α kinases PERK and PKR activate glycogen synthase kinase 3 to promote the proteasomal degradation of p53
Dionissios Baltzis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The p300/CBP-associated factor (PCAF) is a cofactor of ATF4 for amino acid-regulated transcription of CHOP
Yoan Cherasse et al.
NUCLEIC ACIDS RESEARCH (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
MX Bi et al.
EMBO JOURNAL (2005)
A random variance model for detection of differential gene expression in small microarray experiments
GW Wright et al.
BIOINFORMATICS (2003)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
Translational control is required for the unfolded protein response and in vivo glucose homeostasis
D Scheuner et al.
MOLECULAR CELL (2001)
Altered HOX and WNT7A expression in human lung cancer
R Calvo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
